Portal
Watertown
About Portal
Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: portal.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/portal-71596 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.